Advertisement

Topics

NeoTract Announces Publication of Five-Year Results from Pivotal Trial of the UroLift® System

08:00 EDT 30 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Treatment for BPH Now “Standard of Care” According to Study Investigators; Results Published in Canadian Journal of Urology NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urolo...

Other Sources for this Article

for NeoTract, Inc.
Nicole Osmer, 650-454-0504
nicole@healthandcommerce.com

NEXT ARTICLE

More From BioPortfolio on "NeoTract Announces Publication of Five-Year Results from Pivotal Trial of the UroLift® System"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...